ClinicalTrials.Veeva

Menu

Efficacy of TEAS On Prevention of Propofol Injection Pain in Children

K

Konya Meram State Hospital

Status

Enrolling

Conditions

Injection Site

Treatments

Device: TEAS

Study type

Interventional

Funder types

Other

Identifiers

NCT05296187
TEAS Propofol Injection Pain

Details and patient eligibility

About

The purpose of this study is to determine the efficacy of transcutaneous electrical acupoint stimulation for the prevention of propofol injection pain in children.

Full description

Pain from the injection of propofol is a common side effect during anesthetic practice. Various methods have been used to reduce this pain. This prospective, randomized study was designed to determine the efficacy of transcutaneous electrical acupuncture point stimulation in reducing propofol injection pain in children.

Enrollment

60 estimated patients

Sex

All

Ages

6 to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA I-II and aged 6-13 years patents who will undergo elective surgery under general anesthesia

Exclusion criteria

  • patients with propofol allergy
  • patients who have renal, hepatic, cardiac, neurological, psychiatric disease
  • Cardiac and cranial surgery
  • Pacemaker,
  • Emergency surgery and patients requiring rapid serial induction

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

GROUP TEAS
Active Comparator group
Description:
Patients will receive TEAS bilaterally at two acupoints: Hegu (L14) and Neiguan (PC6).
Treatment:
Device: TEAS
Control Sham Group
Placebo Comparator group
Description:
Patients in the sham group will be undergoing electrode attachment on the target acupoints without electronic stimulation.
Treatment:
Device: TEAS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems